We address untreated epilepsy by funding training for healthcare providers (physicians, nurses, neurodiagnostic technicians, and community health workers), providing diagnostic (EEG) equipment, and making grants of psychiatric and anti-seizure medications for clinical settings and research. We're also interested in innovative ways to solve problems through community health worker models, telemedicine and research.
We're happy to begin a conversation with organizations and individuals who share our mission to reduce treatment gaps for epilepsy and psychiatric disorders in under-resourced areas of the world. While we're a funder of epilepsy programs, we also seek the support of larger funders for new programs to accelerate our ability to meet the diagnosis and treatment needs of the millions of people with untreated epilepsy in under-resourced areas.
Since 2015, ROW Foundation has facilitated grants of EEG equipment to hospitals in Armenia, Bolivia, Ecuador, Ghana, India, Kenya, Republic of Georgia, Sierra Leone, Sudan and Uganda for the diagnosis of epilepsy and we've supported training programs for healthcare providers globally. We grant ongoing supplies of Roweepra® (levetiracetam) and Subvenite® (lamotrigine) to partners in 25 countries, as well as emergency humanitarian medication aid to Ukraine and Venezuela.